Clinical Trials Directory

Trials / Unknown

UnknownNCT05197608

At-risk and vulNerable Individuals To Infection With COVID-19 and ProActive inTervention With intEgrated Health and Social Care

At-risk and vulNerable Individuals To Infection With COVID-19 and ProActive inTervention With intEgrated Health and Social Care (ANTICIPATE): a Pragmatic Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Unity Health Toronto · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

This randomized control trial aims to explore a data-driven, proactive approach to identifying patients at greatest risk during the pandemic, and assess the impact of an embedded System Navigator in a primary health care setting. The System Navigator works one-on-one with patients to identify and provide support to their biological, psychological and social needs (e.g. income, housing, food security). Investigators are doing this study to find out whether proactive identification of vulnerable patients and linking to a System Navigator leads to reduction in emotional distress associated with managing complex health conditions and unmet social needs during COVID-19, compared to usual care. Investigators will involve approximately 180 patients from primary care clinics that are a part of the University of Toronto Practice-Based Research Network (UTOPIAN). The information from this study will be used to help us understand how proactive engagement within a primary health setting can help to improve the health of patients during COVID-19, and beyond.

Conditions

Interventions

TypeNameDescription
OTHERSystem NavigatorParticipants will be connected to a System Navigator, who is a trained staff embedded within their primary health clinic to support and help navigate biological, psychological and social needs in proactively identified vulnerable patients.
OTHERTailored list of resourcesControl group will be provided a tailored list of resources

Timeline

Start date
2022-02-25
Primary completion
2024-01-01
Completion
2024-03-01
First posted
2022-01-19
Last updated
2023-12-04

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05197608. Inclusion in this directory is not an endorsement.